Bye bye Ozempic: Eli Lilly says its new drug retatrutide more than doubles weight loss

Fonte: Business Insider

Retatrutide, Eli Lilly's "triple G" injection, is still in clinical development. Kateryna Borodina/Getty ImagesEli Lilly is developing a more potent weight-loss drug called retatrutide. In the first head-to-head trial versus Ozempic, retatrutide takers lost roughly twice as much weight.